Assessment of cognition in mild cognitive impairment: A comparative study

Alzheimer's and Dementia

Volumn 7, Issue 3, 2011, Pages 338-355

  Snyder, Peter J ^a,b   Jackson, Colleen E ^c   Petersen, Ronald C ^d   Khachaturian, Ara S ^e   Kaye, Jeffrey ^f   Albert, Marilyn S ^g   Weintraub, Sandra ^h  

^a Lifespan   (United States)

^b BROWN UNIVERSITY   (United States)

^c UNIVERSITY OF CONNECTICUT   (United States)

^d MAYO CLINIC   (United States)

^e Campaign to Prevent Alzheimer's Disease by 2020 PAD2020   (United States)

^f OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^g JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Alzheimer's disease; Clinical trials; Cognition; Mild cognitive impairment; Neuropsychological assessment

Indexed keywords

ALZHEIMER DISEASE; AUTOMATED COGNITIVE TEST; AUTOMATED NEUROPSYCHOLOGICAL ASSESSMENT METRICS; COGNITION; COGNITIVE DRUG RESEARCH COMPUTERIZED ASSESSMENT SYSTEM FOR DEMENTIA; COMMUNITY SCREENING INSTRUMENT FOR DEMENTIA; COMPARATIVE STUDY; COMPUTER ADMINISTERED NEUROPSYCHOLOGICAL SCREEN FOR MILD COGNITIVE IMPAIRMENT; COMPUTER ASSESSMENT OF MILD COGNITIVE IMPAIRMENT; COMPUTERIZED SELF TEST; FLORIDA BRIEF MEMORY SCALE; GRAYMATTERS ASSESSMENT SYSTEM; HUMAN; INTEGNEURO WEBNEURO; MILD COGNITIVE IMPAIRMENT; MILD COGNITIVE IMPAIRMENT SCREEN; MINDSTREAMS; NEUROPSYCHOLOGICAL TEST; NEUROPSYCHOLOGICAL TEST BATTERY; NIH TOOLBOX; PRIORITY JOURNAL; QUESTIONNAIRE; REVIEW; SYSTEMATIC REVIEW; VITAL SIGNS NEUROCOGNITIVE ASSESSMENT BATTERY;

EID: 79956070940     PISSN: 15525260     EISSN: 15525279     Source Type: Journal    
DOI: 10.1016/j.jalz.2011.03.009     Document Type: Article

References (44)

1. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadian EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-44.
2. Khachaturian ZS. Diagnosis of Alzheimer's disease. Arch Neurol 1985;42:1097-105. (Pubitemid 16236926)
3. Jack CR Jr, Knopman DS, Jagust WJ, Shaw LM, Aisen PS, Weiner MW, et al. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol 2010;9:119-28.
4. Jack CR Jr, Wiste HJ, Vemuri P, Weigand SD, Senjem ML, Zeng G, et al. Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease. Brain 2010;133:3336-48.
5. Lopez OL, Schwam E, Cummings J, Gauthier S, Jones R, Wilkinson D, et al. Predicting cognitive decline in Alzheimer's disease: an integrated analysis. Alzheimers Dement 2010;6:431-9.
6. Jack CR Jr, Petersen RC, Grundman M, Jin S, Gamst A, Ward CP, et al. Longitudinal MRI findings from the vitamin E and donepezil treatment study for MCI. Neurobiol Aging 2008;29:1285-95. (Pubitemid 351970601)
7. Petersen RC, Thomas RG, Grundman M, Bennett D, Doody R, Ferris S, et al. Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med 2005;352:2379-88. (Pubitemid 40958434)
8. Cummings JL, Doody R, Clark C. Disease-modifying therapies for Alzheimer disease: challenges to early intervention. Neurology 2007;69:1622-34. (Pubitemid 350287147)
9. Evans DA, Grodstein F, Loewenstein D, Kaye J, Weintraub S. Reducing case ascertainment costs in US population studies of Alzheimer's disease, dementia, and cognitive impairment. Alzheimers Dement 2011;7:94-109.
10. Harrison J, Maruff P. Measuring the mind: assessing cognitive change in clinical drug trials. Expet Rev Clin Pharmacol 2008;1:471-3.
11. Nestor PJ, Scheltens P, Hodges JR. Advances in the early detection of Alzheimer's disease. Nat Med 2004;10:S34-41.
12. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999;56:303-8. (Pubitemid 29120227)
13. Ellis KA, Bush AI, Darby D, De Fazio D, Foster J, Hudson P, et al. The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease. Int Psychogeriatr 2009;21:672-87.
14. Kaldi A, Ellis KA, Darby D, Ames D, Martins R, Masters CL, et al. Determining rate of decline in pre-AD and AD AIBL participants using a brief computerized battery. Alzheimers Dement 2010;6:S341-2.
15. Wild K, Howieson D, Webbe F, Seelye A, Kaye J. Status of computerized cognitive testing in aging: a systematic review. Alzheimers Dement 2008;4:428-37.
16. PAD2020.org [Internet]. Rockville, MD: PAD2020; c2011 [updated April 7, 2011]. Available at: http://www.pad2020.org.
17. Gualtieri CT, Johnson LG. Neurocognitive testing supports a broader concept of mild cognitive impairment. Am J Alzheimers Dis Other Dement 2005;20:359-66. (Pubitemid 43030925)
18. Nicholl CG, Lynch S, Kelly CA, White L, Simpson PM, Wesnes KA, et al. The cognitive drug research computerized assessment system in the evaluation of early dementia - is speed of the essence? Int J Ger Psychiatry 1995;10:199-206.
19. Darby D, Pietrzak RH, Fredrickson J, Woodward M, Moore L, Fredrickson A, Sach J, Maruff P. Intra-individual cognitive decline using a brief computerized cognitive screening test. Alzheimers Dement 2011; in press.
20. Saxton J, Morrow L, Eschman A, Archer G, Luther J, Zuccolott A. Computer assessment of mild cognitive impairment. Postgrad Med 2009;121:177-85.
21. Dougherty JH, Cannon RL, Nicholas CR, Hall L, Hare F, Carr E, et al. The Computerized Self Test: an interactive, Internet accessible cognitive screening test for dementia. J Alzheimers Dis 2010;20:185-95.
22. Loewenstein DA, Acevedo A, Small BJ, Agron J, Crocco E, Duara R. Stability of different subtypes of mild cognitive impairment among the elderly over a 2- to 3-year follow-up period. Dement Geriatr Cogn Disord 2009;27:418-23.
23. Dwolatzky T, Whitehead V, Doniger GM, Simon ES, Schweiger A, Jaffe D, Chertkow H. Validity of a novel computerized cognitive battery for mild cognitive impairment. BMC Geriatr 2003;3:4.
24. Harrision J, Minassian SL, Jenkins L, Black RS, Koller M, Grundman M. A neuropsychological test battery for use in Alzheimer disease clinical trials. Arch Neurol 2007;64:1323-9. (Pubitemid 47403089)
25. Gualtieri CT, Boyd AF. Sensitivity and specificity of computerized testing for MCI. In: International Congress for Alzheimer's Disease, 2008, Chicago, IL.
26. Levinson D, Reeves D, Watson J, Harrison M. Automated neuropsychological assessment metrics (ANAM) measures of cognitive effects of Alzheimer's disease. Arch Clin Neuropsychol 2005;20:403-8. (Pubitemid 40431784)
27. Wesnes K, Brooker H, Newhouse P, Levin E, White H, Coderre E, et al. The profile of cognitive impairment in MCI. In: International Society for CNS Clinical Trials and Methodology, 2009, San Diego, CA.
28. Ballard CG, O'Brien JT, Gray A, Cormack F, Ayre G, Rowan EN, et al. Attention and fluctuating attention in patients with dementia with Lewy bodies and Alzheimer disease. Arch Neurol 2001;58:977-82. (Pubitemid 32537473)
29. Ballard CG, Walker M, O'Brien JT, Rowan EN, McKeith IG. The characterization and impact of 'fluctuating' cognition in dementia with Lewy bodies and Alzheimer's disease. Int J Geriatr Psychiatry 2001;16:494-8.
30. Walker MP, Ayre GA, Ashton CH, Marsh VR, Wesnes KA, Perry EK, et al. A psychophysiological investigation of fluctuating consciousness in neurodegenerative dementias. Hum Psychopharm Clin 1999;14:483-9. (Pubitemid 29490730)
31. Walker MP, Ayre GA, Cummings JL, Wesnes KA, McKeith IG, O'Brien JT, et al. Quantifying fluctuation in dementia with Lewy bodies, Alzheimer's disease, and vascular dementia. Neurology 2000;54:1616-25.
32. Walker MP, Ayre GA, Perry EK, Wesnes KA, McKeith IG, Tovee M, et al. Quantification and characterization of fluctuating cognition in dementia with Lewy bodies and Alzheimer's disease. Dement Geriatr Cogn Disord 2000;11:327-35.
33. Darby D, Maruff P, Collie A, Weaver-Cargin J, Masters C, Currie J. Reliable detection of asymptomatic longitudinal cognitive decline in healthy community dwelling volunteers. In: American Geriatrics Society Meeting, 2004, Las Vegas, NV.
34. Pietrzak RH, Maruff P, Mayes LC, Roman SA, Sosa JA, Snyder PJ. An examination of the construct validity and factor structure of the Groton Maze Learning Test, a new measure of spatial working memory, learning efficiency, and error monitoring. Arch Clin Neuropsychol 2008;23:433-45.
35. Hall KS, Gao S, Emsley CL, Ogunniyi AO, Morgan O, Hendrie HC. Community Screening Interview for Dementia (CSI 'D'); performance in five disparate study sites. Int J Geriatr Psychiatry 2000;15:521-31. (Pubitemid 30409994)
36. Tornatore JB, Hill E, Laboff JA, Fogel B. Preliminary screening for Mild Cognitive Impairment (MCI): using the CANS-MCI in primary care to determine need for imaging. In: International Conference of Alzheimer's Disease, 2004, Philadelphia, PA.
37. Brand N, Jolles J. Learning and retrieval rate of words presented auditorily and visually. J Gen Psychol 1985;112:201-10.
38. Shankle WR, Romney AK, Hara J, Fortier D, Dick M, Chen J, et al. Method to improve the detection of mild cognitive impairment. PNAS 2005;102:4919-24. (Pubitemid 40471554)
39. Simon ES, Goldstein FC, Lah JJ, Doniger GM, Levey AI, Dwolatzky T. Computerized cognitive assessment predicts conversion to dementia within two years: Interim analysis of a prospective study of MCI. In: International Conference on the Prevention of Dementia, 2007, Washington, DC.
40. Weintraub S, Dikmen SS, Heaton RK, Tulsky DS, Zelazo PD, Bauer PJ, et al. NIH Toolbox for the Assessment of Behavioral and Neurological Function: cognition domain instruments. Neurology (in press).
41. Tierney MC, Lerner MA. Computerized cognitive assessment in primary care to identify patients with suspected cognitive impairment. J Alzheimers Dis 20:823-832.
42. Farias ST, Mungas D, Reed BR, Cahn-Weiner D, Jagust W, Baynes K, et al. The measurement of everyday cognition (ECog): scale development and psychometric properties. Neuropsychology 2008;22:531-44. (Pubitemid 351992899)
43. Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, et al. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011;7:270-9.
44. Festa EK, Heindel WC, Ott BR. Dual-task conditions modulate the efficiency of selective attention mechanisms in Alzheimer's disease. Neuropsychologia 2010;48:3252-61.